About Lantern Pharma

Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also

Repeat Founder
Company Highlights
Year Founded

2013

icon-altEmployees

28

Location (HQ)

USA

Since Last Funding

3 years 8 months

Monthly Website Visitors

20.6K

icon-altTotal Investment Amt

$95M

Last Funding Round

Post Ipo Secondary

icon-altYoY Headcount Growth

21.65%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical

Biotechnology

Biotechnology Research

Therapeutics

Biopharma

Oncology